Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GÖHRING, Gudrun")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 26

  • Page / 2
Export

Selection :

  • and

MDR1 modulators improve the chemotherapy response of human hepatoblastoma to doxorubicin in vitroWARMANN, Steven; GÖHRING, Gudrun; TEICHMANN, Birgit et al.Journal of pediatric surgery. 2002, Vol 37, Num 11, pp 1579-1584, issn 0022-3468, 6 p.Article

Prenatal Diagnosis of an Epignathus Associated with a 49,XXXXY Karyotype : A Case ReportSTABOULIDOU, Ismini; MILLER, Konstantin; GOHRING, Gudrun et al.Fetal diagnosis and therapy. 2008, Vol 24, Num 3, pp 313-317, issn 1015-3837, 5 p.Article

P-Glycoprotein modulation improves in vitro chemosensitivity in malignant pediatric liver tumorsWARMANN, Steven; GÖHRING, Gudrun; TEICHMANN, Birgit et al.Anticancer research. 2003, Vol 23, Num 6C, pp 4607-4611, issn 0250-7005, 5 p.Article

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progressionJÄDERSTEN, Martin; SAFT, Leonie; PELLAGATTI, Andrea et al.Haematologica (Roma). 2009, Vol 94, Num 12, pp 1762-1766, issn 0390-6078, 5 p.Article

Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomideGÖHRING, Gudrun; GIAGOUNIDIS, Aristoteles; BÜSCHE, Guntram et al.Haematologica (Roma). 2011, Vol 96, Num 2, pp 319-322, issn 0390-6078, 4 p.Article

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AMLKAYSER, Sabine; DÖHNER, Konstanze; RUMMEL, Mathias et al.Blood. 2011, Vol 117, Num 7, pp 2137-2145, issn 0006-4971, 9 p.Article

Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategiesKAYSER, Sabine; ZUCKNICK, Manuela; GERMING, Ulrich et al.Blood. 2012, Vol 119, Num 2, pp 551-558, issn 0006-4971, 8 p.Article

TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease ProgressionJÄDERSTEN, Martin; SAFT, Leonie; HELLSTRÖM-LINDBERG, Eva et al.Journal of clinical oncology. 2011, Vol 29, Num 15, pp 1971-1979, issn 0732-183X, 9 p.Article

Persistent Malignant Stem Cells in del(5q) Myelodysplasia in RemissionTEHRANCHI, Ramin; WOLL, Petter S; RAKESH SINGH DHANDA et al.The New England journal of medicine. 2010, Vol 363, Num 11, pp 1025-1037, issn 0028-4793, 13 p.Article

A tumor-derived population (SCCOHT-1) as cellular model for a small cell ovarian carcinoma of the hypercalcemic typeOTTE, Anna; GÖHRING, Gudrun; PARK-SIMON, Tjoung-Won et al.International journal of oncology. 2012, Vol 41, Num 2, pp 763-773, issn 1019-6439, 11 p.Article

Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and ―5/5q―MIDDEKE, Jan M; BEELEN, Dietrich; SCHWERDTFEGER, Rainer et al.Blood. 2012, Vol 120, Num 12, pp 2521-2528, issn 0006-4971, 8 p.Article

Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study GroupKRÖNKE, Jan; SCHLENK, Richard F; SPÄTH, Daniela et al.Journal of clinical oncology. 2011, Vol 29, Num 19, pp 2709-2716, issn 0732-183X, 8 p.Article

Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IVFABARIUS, Alice; LEITNER, Armin; JUNG-MUNKWITZ, Susanne et al.Blood. 2011, Vol 118, Num 26, pp 6760-6768, issn 0006-4971, 9 p.Article

Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndromeGÖHRING, Gudrun; MICHALOVA, Kyra; STARY, Jan et al.Blood. 2010, Vol 116, Num 19, pp 3766-3769, issn 0006-4971, 4 p.Article

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromesTHOL, Felicitas; KADE, Sofia; GÖHRING, Gudrun et al.Blood. 2012, Vol 119, Num 15, pp 3578-3584, issn 0006-4971, 7 p.Article

Occurrence of Acute Lymphoblastic Leukemia and Juvenile Myelomonocytic Leukemia in a Patient With Noonan Syndrome Carrying the Germline PTPN11 Mutation p.E139DPAULI, Silke; STEINEMANN, Doris; DITTMANN, Kai et al.American journal of medical genetics. Part A. 2012, Vol 158, Num 3, pp 652-658, issn 1552-4825, 7 p.Article

Prognostic Importance of Histone Methyltransferase MLL5 Expression in Acute Myeloid LeukemiaDAMM, Frederik; OBERACKER, Tina; KANZ, Lothar et al.Journal of clinical oncology. 2011, Vol 29, Num 6, pp 682-689, issn 0732-183X, 8 p.Article

Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic SyndromesTHOL, Felicitas; FRIESEN, Inna; GÖHRING, Gudrun et al.Journal of clinical oncology. 2011, Vol 29, Num 18, pp 2499-2506, issn 0732-183X, 8 p.Article

Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignanciesKÜMPERS, Philipp; KOENECKE, Christian; DAVID, Sascha et al.Blood. 2008, Vol 112, Num 5, pp 2139-2148, issn 0006-4971, 10 p.Article

Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-HOXD13―driven mouse modelHAIMING XU; MENENDEZ, Silvia; SCHLEGELBERGER, Brigitte et al.Blood. 2012, Vol 120, Num 15, pp 3089-3097, issn 0006-4971, 9 p.Article

Constitutional trisomy 8p11.21-q11.21 mosaicism: a germline alteration predisposing to myeloid leukaemiaRIPPERGER, Tim; TAUSCHER, Marcel; STEINEMANN, Doris et al.British journal of haematology. 2011, Vol 155, Num 2, pp 209-217, issn 0007-1048, 9 p.Article

FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotypeWAGNER, Katharina; DAMM, Frederik; KRAUTER, Jürgen et al.Haematologica (Roma). 2011, Vol 96, Num 5, pp 681-686, issn 0390-6078, 6 p.Article

Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid LeukemiaTHOL, Felicitas; DAMM, Frederik; LÜBBERT, Michael et al.Journal of clinical oncology. 2011, Vol 29, Num 21, pp 2889-2896, issn 0732-183X, 8 p.Article

IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosisTHOL, Felicitas; WEISSINGER, Eva M; HOFMANN, Wolf-Karsten et al.Haematologica (Roma). 2010, Vol 95, Num 10, pp 1668-1674, issn 0390-6078, 7 p.Article

Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemiaTHOL, Felicitas; DAMM, Frederik; RAGHAVACHAR, Aruna et al.Blood. 2010, Vol 116, Num 4, pp 614-616, issn 0006-4971, 3 p.Article

  • Page / 2